© Springer International Publishing Switzerland 2015
Javier Fandino, Serge Marbacher, Ali-Reza Fathi, Carl Muroi and Emanuela Keller (eds.)Neurovascular Events After Subarachnoid HemorrhageActa Neurochirurgica Supplement12010.1007/978-3-319-04981-6_59Blood Clot Placement Model of Subarachnoid Hemorrhage in Non-human Primates
(1)
Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland
(2)
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Abstract
Despite ongoing extensive and promising research to prevent and treat cerebrovascular vasospasm and delayed ischemic neurological deficits (DIND) after aneurysmal subarachnoid hemorrhage (aSAH), clinical outcomes remain unsatisfying. Neuroprotective strategies developed in basic science research laboratories need to be translated from bench-to-bedside using appropriate animal models. While a primate model is widely accepted as the best animal model mimicking development of delayed cerebral vasospasm after aSAH, its worldwide usage has dramatically decreased because of ethical and financial limitations. However, the use of primate models of subarachnoid hemorrhage (SAH) remains a recommended bridge for translation of early preclinical studies in rodents to human clinical trials. This paper discusses the technical aspects as well as advantages and disadvantages of a blood clot placement model of subarachnoid hemorrhage in non-human primates.
Keywords
Subarachnoid hemorrhageAnimal modelPrimatesBlood clot placementIntroduction
Delayed ischemic neurological deficits (DIND) and ischemic brain injury following aneurysmal subarachnoid hemorrhage (aSAH) remain the most challenging and frustrating conditions for physicians dealing with patients after the rupture of an intracranial aneurysm [1]. Ongoing research is still of utmost importance because no effective treatment has been developed thus far. The traditional research roadmap to develop new treatment strategies or diagnostic paradigms usually is initiated by results of studies involving in vitro/ex vivo molecular mechanisms and cell-based targets. Then, the first-line in vivo experiments are performed in rodent models. For decades, non-human primate models served as a bridge for the translational clinical applications of innovative scientific findings. Primates have contributed to numerous major steps in medicine beginning from the early 1900s when typing of blood and use of plasma components were initiated. Numerous pharmacological agents and immunology treatments, including therapies for brain disorders, have become gold standards after successful confirmation of their usefulness in primate models. However, recent financial and well-founded ethical issues have raised concerns about the justification of primate experiments, subsequently leading to increasing levels of restriction for the use of these models.
The primate clot-placement model has served as the best available model for research of delayed events after subarachnoid hemorrhage (SAH) in the past decades [2–5]. Despite all of the concerns, it still remains crucial for the development of successful treatments for DIND and vasospasm following aSAH. This paper summarizes the key procedural steps of this model.
Animals
Cynomolgus monkeys (Macaca fascicularis) each weighing between 3.5 and 8 kg are used in this model. These animals have a gyrencephalic brain with similar cortical and subcortical anatomy to humans. They also have been used in permanent and transient middle cerebral artery (MCA) occlusion models [6, 7]. Their vascular anatomy very much resembles that of the human aside from a single pericallosal artery and more efficient collateralization than human neurovasculature. The primates rarely develop stroke or neurological deficits in the case of accidental ICA occlusion on one side. However, among the macaques, the neurovascular anatomy of the M. fascicularis has less collateralization than M. mulatta and might be more appropriate in stroke models where ischemic lesions are required [6]. The study goals and outcome parameters must be carefully taken into account when choosing the appropriate primate species. The clear advantage of using a non-human primate is their ability to deliver neurobehavioral information, including a greater series of tasks and neurological assessments for grade of consciousness, motor control, memory, and learning that mimics human testing.
Anesthesia
General anesthesia is induced by the injection of ketamine (10 mg/kg) and xylazine (1 mg/kg) followed by tracheal intubation. Anesthesia is maintained by inhaled isoflurane (0.5–1.0 %). Blood pressure, heart rate, rectal body temperature, and end-tidal CO2 can be continuously monitored during anesthesia and for the duration of the experiment. Sodium thiopental (25 mg/kg) and cefazolin (500 mg) are injected at the beginning of cranial surgery.
Craniotomy and Clot Placement
This surgical technique has been slightly modified as described elsewhere [1, 3]. All procedures are performed under general anesthesia and aseptic conditions with the skin of the surgical field shaved. The animals are placed in a supine position with the head extended backwards and held in a slightly lateral position with tapes on a foam head holder. After shaving and the standard antiseptic preparation, the skin is incised in a semicircular fashion and the temporal muscle is dissected from the fronto-temporal bone using monopolar cautery. The fronto-temporal craniectomy is performed using high-speed cutting and diamond drills. After opening the dura mater, the Sylvian fissure is opened under the surgical microscope and the arachnoid is dissected from the proximal 14 mm of the right MCA, distal internal carotid artery, and proximal anterior cerebral artery. Autologous blood is collected from the left femoral artery and allowed to clot for approximately 15 min. Five milliliters of clot is placed around the exposed arteries. The dura is closed in a watertight fashion and the wound is closed. Animals are returned to their cages for monitoring of clinical parameters and neurological deficits. For sham controls, the same procedure is performed without placement of the blood clot. Because the pressure of the blood clot itself may cause some cortical damage or arterial irritation, the placement of fibrin glue or an artificial collagen clot without blood cell components might alternatively be considered.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

